The urinary excretions of the free catecholamines noradrenaline, adrenaline and dopamine were measured in 50 patients (33 men and 17 women) with chronic renal failure. Stability studies showed that the catecholamines were stable in unacidified urine as long as the pH was not greater than 7·5 and the urine was acidified within 2-3 h of collection. The outputs of noradrenaline and dopamine correlated positively with creatinine clearance and in patients with clearances above 40 ml.jrnin were similar to those in healthy volunteers (n = 20). However, adrenaline output was not correlated with creatinine clearance although it was lower in patients with renal failure compared with healthy volunteers. The urinary free catecholamine output during the first 10 days after a renal transplant was significantly less than normal, presumably because renal function was still impaired. However, in patients treated with cyclosporin A (CyA) combined with prednisolone the catecholamine excretion was lower compared with those treated with CyA and azathioprine. Impairment in renal function can have a marked effect on the output of free catecholamines and must be borne in mind when interpreting values that may have pathological significance.
INTRODUCTION
It is well established that urinary dopamine output declines with falling glomerular filtration rate. 1.2 However, similar studies of noradrenaline and adrenaline or the catecholamine metabolites have produced conflicting results.P" The explanation for such findings could be that the major proportion of urinary dopamine is of renal origin whereas urinary noradrenaline and adrenaline are primarily extra-renal in origin.' However, renal function (as assessed by the glomerular filtration rate) is dependent on the number of effective nephrons and thus concentrations of all the catecholamines would be expected to decrease. To investigate this further we have studied the renal excretion of free catecholamines in patients with varying degrees of renal failure and in patients after renal transplantation. Of particular interest were the effects of improvement in renal function and of the immunosuppressive regimen on catecholamine excretion. One of the problems with urine collection in patients with renal disease is the Correspondence: N B Roberts. requirement for measurement of other markers e.g. N-acetylglucosaminidase, for which acidification is contraindicated. We have therefore investigated aspects of catecholamine stability in urine.
MATERIALS AND METHODS
Fifty patients (33 men and 17 women) with varying renal function as assessed by creatinine clearance (CrCI) were studied. Patients had renal disease of varying aetiology' but patients with amyloidosis or tuberculosis infection were excluded as these conditions may be associated with adrenal dysfunction. A single 24-h urine sample was collected into 50 mL 0·5 mol/L sulphuric acid. The volume and pH were measured using a pH meter (model 120 Corning, S&M Products, Manchester UK) and a 10mL aliquot stored at -20 D e. The pH of these samples varied and they were therefore divided into two groups: group I, with pH less than 4·0 (n = 22); and group II, with pH greater than 4·0 but less than 7·5 (n=28). In the latter group, the sample aliquot was acidified immediately (usually 1-2 drops of l Grnol/L H 2S04 ) to pH 2-3 and the sample stored as above. Urine was also collected from patients during the first 10 days immediately after a renal allograft transplant. The immunosuppression regime consisted of cyclosporin A (CyA) supplemented with prednisolone 20 mg/day (n = 10) or azathioprine 50 mg/day (n= 10). The dose ofCyA in the immediate posttransplant phase was between 10-12·5 mg/kg taken twice daily and was titrated to give whole blood CyA concentration of 250-350/lg/L by highperformance liquid chromatography (HPLC) equivalents."
To study the stability of catecholamines, 24-h urine samples were collected without acidification from 20 healthy volunteers, and 10 of these samples were aliquoted and acidified. In the remaining 10 samples, one aliquot was immediately acidified to pH 2-3, and the pH ofa second aliquot was recorded. All samples were then stored at -20°C. Separate aliquots of these acidified and untreated urine samples were also left at room temperature (l5-20°C) for 7 days and then stored at -20°C to assess the catecholamine loss. The catecholamines when stored at -20°C have been shown to be stable for at least 2 months, although analysis in this study was always carried out within 10 working days.
Urinary free noradrenaline, adrenaline and dopamine were measured by a fully automated procedure (ASTED; Anachem/Gilson, Luton, UK) using electrochemical detection after separation by ion-pair reversed phase HPLC as previously reported.Y The procedure gives excellent analytical precision with between-batch co-efficients of variation (n = 10) of 3·5 and 4,6%, 4·0 and 5·2%, and 4·6 and 4·0%, at concentrations of 300 and 1000 nmol/L noradrenaline; 50 and 200 nmol/L adrenaline, and 500 and 2000nmol/L dopamine, respectively. The lower limits of detection under these conditions are 1-2 nmol/L for noradrenaline and adrenaline and 10 nmol/L for dopamine, and values at or below these limits were classified as 0 in the figures presented.
The data were analysed by standard linear regression, paired r-test and Mann-Whitney U test. A P value of < 0·05 was classified as statistically significant. 
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(1) Table 1 shows that the catecholamines in un acidified urine were stable at room temperature (15-20°C) for up to 7 days. However, when the urine was kept for 28 days, significant losses of up to 80--100% were observed in all the samples (data not shown). In samples left in acid conditions at room temperature the measured free catecholamine increased by about 20% (P < 0,05), indicating a tendency for hydrolysis of the catecholamine conjugates. There were no significant differences between the two groups of renal failure patients for any of the analytes (fig. I) . Therefore, the results were combined for further analysis. The catecholamine excretion in renal failure was significantly lower (P<O·OI) than that in healthy controls. Excretion of noradrenaline and dopamine decreased with falling creatinine clearance; however, adrenaline excretion showed no such dependence ( fig. 2 ).
The catecholamine excretion during the first 10 days after renal transplantation (see Table 2 ) confirmed the observation that impaired renal function (relatively low creatinine clearance) was associated with reduced noradrenaline, adrenaline and dopamine outputs. Furthermore, the patients on prednisolone had significantly lower catecholamine output (P < 0,05). recommended's!", It is also important that samples are not acidified to a very low pH (< O· 5-1 '0) as the free catecholamine content may increase due to hydrolysis of the conjugates. If urine is required for other analyses, such as protein and enzyme activities, very low pH ( < 1'0) can also have significant effects on these analytical procedures. Free catecholamines in urine collected without an acid preservative were shown to be stable for 24 h when kept at room temperature as long as the urine pH was not greater than 7,5. 9 , 10 If the pH is greater than 8,5, the catecholamines are more sensitive to oxidation. As we cannot predict urine pH or time delay in receiving the sample, our preferred policy is to collect urine into acid. Addition of other preservatives such as EDTA, glutathione or sodium metabisulphite!' can be useful. However, the catecholamines are unstable in urine stored this way for more than 20 days. 1 I This later study also confirmed that the free catecholamine content in urine acidified to pH < 1·5 and left at room temperature for several days increased.'! The data obtained from the renal failure patients clearly show that the urinary outputs Ann Clin Biochem 1999: 36 of both noradrenaline and dopamine are significantly lower and are related to creatinine clearance, as previously reported for dopamine.' Values above the lower limits of normal for noradrenaline and dopamine excretion (120 and 600 nmol/24 h, respectively'F) were observed only when creatinine clearance was at least 30-40 ml.jmin, Adrenaline output was also significantly lower in the renal failure patients but was not related to the creatinine clearance,
The urinary excretion of dopamine, previously shown to be correlated with creatinine clearance,' could be used as an indirect assessment of renal function, and excretion of catecholamines could therefore be related to dopamine as an alternative to creatinine. Thus, increased excretion of noradrenaline or adrenaline relative to dopamine would indicate increased secretion even though the measured values may be within the reference limits. This will be particularly relevant in the investigation of a catecholaminesecreting tumour in patients with poor renal function, or if the urine was not a true 24-h collection. The normal noradrenaline:dopamine and adrenaline:dopamine ratios are 1:5-1: 10 and 1:10-1:50, respectively, and in patients with catecholamine-secreting tumours the ratios would be between I:I and I:3 based on calculations from published data,12,13 A similar argument has been suggested for the catecholamine metabolites homovanillic acid and 3methoxy-4-hydroxymandelic acid." A ratio greater than 1:2-4 indicated a possible catecholamine-secreting tumour. This will not apply to patients on L-dopa therapy, in whom disproportionate increases in urinary dopamine and its metabolites will occur.'! The consistently low excretion of adrenaline ( < 1-2 nrnol/L) in a significant number of the renal failure patients suggests impaired adrenal output as a result of drug therapy, renal failure or both, However, the use of drugs such as angiotensin-converting enzyme inhibitors, calcium antagonists, fJ blockers or steroids was similar in patients with and without very low adrenaline excretion. The addition of steroids, however, did appear to reduce the catecholamine excretion in transplant patients. The fact that a large number of patients have low adrenaline excretion (less than 1-2 nmol/L) is worthy of further study to establish significance and whether there is a causal link to impaired adrenal function.
In conclusion, this study has shown that free catecholamines can be reliably measured in unacidified urines if the urines are acidified immediately after collection to around pH 3·0 (but not to less than pH 1,0) and stored at -20°C for no longer than 2-3 months. In patients with renal disease, the urinary excretions of dopamine and noradrenaline were less and were related to renal function; adrenaline excretion did not show such a relationship but was significantly less compared with that of healthy volunteers.
